| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 3,572,376 | 2,836,088 | 2,303,580 | | Cost of Revenue | 1,165,966 | 927,638 | 754,290 | | | Gross Profit | 2,406,410 | 1,908,450 | 1,549,290 | | | Operating Expenses | | Research Development | 731,151 | 622,961 | 480,247 | | Selling General and Administrative | 927,777 | 783,177 | 691,581 | | Non Recurring | 13,979 | 9,354 | 1,283,421 | | Others | 38,529 | 85,896 | 91,823 | | | | Total Operating Expenses | 1,711,436 | 1,501,388 | 2,547,072 | | | | Operating Income or Loss | 694,974 | 407,062 | (997,782) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 33,917 | 103,521 | 104,323 | | Earnings Before Interest And Taxes | 728,891 | 510,583 | (893,459) | | Interest Expense |
-
|
-
| 3,590 | | Income Before Tax | 728,891 | 510,583 | (897,049) | | Income Tax Expense | 217,142 | 149,753 | 104,388 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 511,749 | 360,830 | (1,001,437) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 511,749 | 360,830 | (1,001,437) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $511,749 | $360,830 | ($1,001,437) |
|
0.16% Nasdaq 0.00%
Income Statement
